(Total Views: 507)
Posted On: 01/09/2022 6:11:01 AM
Post# of 148878
A study of stock market activity shows that share price is reliant on support and resistance. When you have support (i.e., FDA approval) the share price will likely go higher. When you have resistance (i.e., no news or negative news) the stock price will likely be depressed. It does not seem to matter the source of the news.
In this environment we should expect to see both support and resistance over time. That does not mean the share price is what it's worth today, unless you sell the stock at the lower price.
Buyers will be attracted to stocks that have support. Pretty simple but often painful.
I'm thinking we are going to be fine. Not selling, probably buying more. Tho I must admit I suffer anxiety when we drop through new lows. This too will pass.
As many knowledgeable posters have indicated, LL works.
Why not leronlimab?
In this environment we should expect to see both support and resistance over time. That does not mean the share price is what it's worth today, unless you sell the stock at the lower price.
Buyers will be attracted to stocks that have support. Pretty simple but often painful.
I'm thinking we are going to be fine. Not selling, probably buying more. Tho I must admit I suffer anxiety when we drop through new lows. This too will pass.
As many knowledgeable posters have indicated, LL works.
Why not leronlimab?
(1)
(0)Scroll down for more posts ▼
